Cibc World Market Inc. Ventyx Biosciences, Inc. Transaction History
Cibc World Market Inc.
- $44.5 Billion
- Q1 2025
A detailed history of Cibc World Market Inc. transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 272,500 shares of VTYX stock, worth $689,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
272,500
Previous 67,500
303.7%
Holding current value
$689,425
Previous $148,000
111.49%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VTYX
# of Institutions
127Shares Held
45.8MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$12.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$10.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$8.89 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$7.84 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$6.53 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $143M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...